Cysteinyl leukotrienes (CysLTs)

Role in obesity-induced asthma

U. C S Yadav, Satish Srivastava

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Epidemiological studies associate obesity with onset of asthma, especially in obese children, suggesting obesity as the risk factor for asthma. Obesity-induced chronic inflammation has been implicated in the lung inflammation, yet specific mediators and mechanisms are lacking. Obesity is associated with increased expression of 5-lipoxygenase (5-LO) pathway and increased Leukotrienes (LTs) production has been observed in obese asthma patients. However, the precise mechanism that predisposes lungs inflammation in obese is not clearly understood. This article discusses the production and regulation of LTs in obese individuals and presents probable mechanisms regarding the role of LTs in lung inflammation that may lead to obesity-induced asthma. Leukotrienes are well known mediators of asthma but their role in obesity-induced asthma is not clearly understood and thus needs further research. Since efficient antagonists and inhibitors of 5-LO pathways are known, understanding of molecular mechanism of LTs, especially Cysteinyl-LTs, in obesity-induced asthma could lead to optimal treatment regimens for the prevention and treatment of asthma in obese individuals.

Original languageEnglish (US)
Pages (from-to)598-605
Number of pages8
JournalCurrent Molecular Medicine
Volume15
Issue number7
StatePublished - Sep 1 2015

Fingerprint

Leukotrienes
Asthma
Obesity
Arachidonate 5-Lipoxygenase
Lipoxygenase Inhibitors
Pneumonia
cysteinyl-leukotriene
Pediatric Obesity
Epidemiologic Studies
Inflammation
Therapeutics
Research

Keywords

  • Adipokines
  • Asthma
  • Cysteinyl leukotrienes
  • Lung inflammation
  • Obesity

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine

Cite this

Yadav, U. C. S., & Srivastava, S. (2015). Cysteinyl leukotrienes (CysLTs): Role in obesity-induced asthma. Current Molecular Medicine, 15(7), 598-605.

Cysteinyl leukotrienes (CysLTs) : Role in obesity-induced asthma. / Yadav, U. C S; Srivastava, Satish.

In: Current Molecular Medicine, Vol. 15, No. 7, 01.09.2015, p. 598-605.

Research output: Contribution to journalArticle

Yadav, UCS & Srivastava, S 2015, 'Cysteinyl leukotrienes (CysLTs): Role in obesity-induced asthma', Current Molecular Medicine, vol. 15, no. 7, pp. 598-605.
Yadav, U. C S ; Srivastava, Satish. / Cysteinyl leukotrienes (CysLTs) : Role in obesity-induced asthma. In: Current Molecular Medicine. 2015 ; Vol. 15, No. 7. pp. 598-605.
@article{edc8a912ea3b45e887e4af831cd60f55,
title = "Cysteinyl leukotrienes (CysLTs): Role in obesity-induced asthma",
abstract = "Epidemiological studies associate obesity with onset of asthma, especially in obese children, suggesting obesity as the risk factor for asthma. Obesity-induced chronic inflammation has been implicated in the lung inflammation, yet specific mediators and mechanisms are lacking. Obesity is associated with increased expression of 5-lipoxygenase (5-LO) pathway and increased Leukotrienes (LTs) production has been observed in obese asthma patients. However, the precise mechanism that predisposes lungs inflammation in obese is not clearly understood. This article discusses the production and regulation of LTs in obese individuals and presents probable mechanisms regarding the role of LTs in lung inflammation that may lead to obesity-induced asthma. Leukotrienes are well known mediators of asthma but their role in obesity-induced asthma is not clearly understood and thus needs further research. Since efficient antagonists and inhibitors of 5-LO pathways are known, understanding of molecular mechanism of LTs, especially Cysteinyl-LTs, in obesity-induced asthma could lead to optimal treatment regimens for the prevention and treatment of asthma in obese individuals.",
keywords = "Adipokines, Asthma, Cysteinyl leukotrienes, Lung inflammation, Obesity",
author = "Yadav, {U. C S} and Satish Srivastava",
year = "2015",
month = "9",
day = "1",
language = "English (US)",
volume = "15",
pages = "598--605",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Cysteinyl leukotrienes (CysLTs)

T2 - Role in obesity-induced asthma

AU - Yadav, U. C S

AU - Srivastava, Satish

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Epidemiological studies associate obesity with onset of asthma, especially in obese children, suggesting obesity as the risk factor for asthma. Obesity-induced chronic inflammation has been implicated in the lung inflammation, yet specific mediators and mechanisms are lacking. Obesity is associated with increased expression of 5-lipoxygenase (5-LO) pathway and increased Leukotrienes (LTs) production has been observed in obese asthma patients. However, the precise mechanism that predisposes lungs inflammation in obese is not clearly understood. This article discusses the production and regulation of LTs in obese individuals and presents probable mechanisms regarding the role of LTs in lung inflammation that may lead to obesity-induced asthma. Leukotrienes are well known mediators of asthma but their role in obesity-induced asthma is not clearly understood and thus needs further research. Since efficient antagonists and inhibitors of 5-LO pathways are known, understanding of molecular mechanism of LTs, especially Cysteinyl-LTs, in obesity-induced asthma could lead to optimal treatment regimens for the prevention and treatment of asthma in obese individuals.

AB - Epidemiological studies associate obesity with onset of asthma, especially in obese children, suggesting obesity as the risk factor for asthma. Obesity-induced chronic inflammation has been implicated in the lung inflammation, yet specific mediators and mechanisms are lacking. Obesity is associated with increased expression of 5-lipoxygenase (5-LO) pathway and increased Leukotrienes (LTs) production has been observed in obese asthma patients. However, the precise mechanism that predisposes lungs inflammation in obese is not clearly understood. This article discusses the production and regulation of LTs in obese individuals and presents probable mechanisms regarding the role of LTs in lung inflammation that may lead to obesity-induced asthma. Leukotrienes are well known mediators of asthma but their role in obesity-induced asthma is not clearly understood and thus needs further research. Since efficient antagonists and inhibitors of 5-LO pathways are known, understanding of molecular mechanism of LTs, especially Cysteinyl-LTs, in obesity-induced asthma could lead to optimal treatment regimens for the prevention and treatment of asthma in obese individuals.

KW - Adipokines

KW - Asthma

KW - Cysteinyl leukotrienes

KW - Lung inflammation

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84942122883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942122883&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 598

EP - 605

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 7

ER -